California Oncology Weekly Newsletter 2.28.17

The Center for Cancer Prevention and Treatment at St. Joseph Hospital in Orange invites you to attend: Primary Care and Oncology: Practical Lessons, An Advanced Practice Clinician (Mid-Level) Symposium. This one-day event will be held on April 27th, in Southern California. For more information click here and go under California News.

The California End of Life Option Act is a law that went into effect in June of 2016. This new law allows some patients with terminal diagnosis to receive an aid-in-dying prescription from their physician much like in other states such as Oregon and Washington. In these states, 70-80% of patients who select this option at end of life have cancer. For more information click here and go under California News.

Noridian Medicare Portal Functionality Webinar for Part B Providers – March 23, 2017
The Noridian Provider Outreach and Education (POE) staff is hosting a Noridian Medicare Portal Functionality for Part B Providers webinar on March 23, 2017 at Noon Pacific Time. For more information click here and go under Noridian News.

Members of both political parties introduced legislation in Congress last week calling for the repeal of the Independent Payment Advisory Board (IPAB), a group of presidential appointees charged with making cuts to Medicare once the program reaches an arbitrary spending level, which experts agree will happen this year.  For more information click here and go under National News.

AVOID 2018 MEDICARE PAYMENT ADJUSTMENTS!  CMS has extended the deadline from February 28, 2017 to March 13, 2017 for the 2016 Quality Reporting Document Architecture (QRDA) data submission for the EHR reporting mechanism. This affects Individual eligible professionals (EPs), PQRS group practices, qualified clinical data registries (QCDRs), and qualified EHR data submission vendors (DSVs). For more information click here and go under CMS News.

 

To view the complete California Oncology Weekly Newsletter, click on the date below.

February 28, 2017

The deadline to introduce legislation for this year was Friday, February 17th at 5:00PM.  MOASC is one of many organizations representing patients and providers in opposition to AB 265 (Wood), which would ban patients in California from receiving copayment assistance from a pharmaceutical manufacturer when a therapeutically equivalent or interchangeable brand or generic medication is available at a lower cost.  For more information click here and go under California News.

The California Dialogue on Cancer is pleased to announce the American Cancer Society’s upcoming 80% by 2018 California Colorectal Cancer Roundtable events in Sunnyvale on March 21st and Los Angeles on March 22nd.  The featured speaker for the Roundtables will be Richard Wender, MD, Chief Cancer Control Officer of the American Cancer Society.  For more information click here and go under California News.

On Saturday, March 11, 2017 join nationally known, and regionally based, key-opinion leaders to assess your tools for thriving in an era of Personalized Medicine! Join us for the 2017 MOASC Oncology Summit. There’s an Oncology Revolution going on: Are your treatment choices still relevant in the era of Immuno-oncology and Molecularly-targeted therapies?  We will discuss how to use the new tools of “Personalized Medicine” to guide treatment choices for Lung Cancer, Prostate Cancer and Multiple Myeloma. For more information click here and go under MOASC News.

Drug manufacturers are fighting back against a request by U.S. senators who want HHS Secretary Tom Price to make it easier to import drugs from Canada as a strategy to combat rising drug prices.  For more information click here and go under National News.

AVOID 2018 MEDICARE PAYMENT ADJUSTMENTS!  CMS has extended the deadline from February 28, 2017 to March 13, 2017 for the 2016 Quality Reporting Document Architecture (QRDA) data submission for the EHR reporting mechanism. This affects Individual eligible professionals (EPs), PQRS group practices, qualified clinical data registries (QCDRs), and qualified EHR data submission vendors (DSVs).  For more information click here and go under CMS News.

 

To view the complete California Oncology Weekly newsletter, click on the date below.

February 21, 2017

CMA’s Year-Round Resolutions for Q2 – Testimony Opened yesterday, February 13,
and have approved nine (9) resolutions for consideration in the second quarter (Q2) of the 2016-2017 year-round resolution process. The resolutions have been posted online.  For more information click here and go under California News.

The California Dialogue on Cancer is pleased to announce the American Cancer Society’s upcoming 80% by 2018 California Colorectal Cancer Roundtable events in Sunnyvale on March 21st and Los Angeles on March 22nd.  The featured speaker for the Roundtables will be Richard Wender, MD, Chief Cancer Control Officer of the American Cancer Society.  For more information click here and go under California News.

2017 In-Person Seminars – Your Input Needed. Noridian Provider Outreach and Education (POE) is planning the 2017 In-person seminar topics and locations. As valued members of our Noridian community, we are inviting our providers to participate in a quick survey that will guide us to better serve your needs and improve our events for all attendees. For more information click here and go under Noridian News.

CMS has released their updated telehealth factsheet, reflecting the changes made to Medicare telehealth reimbursement in the CY 2017 fee schedule.  The changes included adding new CPT codes for end-stage renal disease (ESRD) related services for dialysis and advance care planning codes to the list of codes eligible for reimbursement when delivered through telehealth. For more information click here and go under CMS News.

AVOID 2018 MEDICARE PAYMENT ADJUSTMENTS!  CMS has extended the deadline from February 28, 2017 to March 13, 2017 for the 2016 Quality Reporting Document Architecture (QRDA) data submission for the EHR reporting mechanism. For more information click here and go under CMS News.

 

To view the complete California Oncology Weekly Newsletter click on the date below.

February 14, 2017

California Assembly member, Jim Wood, D-Healdsburg, has introduced a bill that would ban drugmakers from issuing coupons that lower patients’ prescription copayments for certain drugs. The bill would prohibit distribution of discount coupons for prescription drugs where a cheaper, FDA-approved equivalent exists. Wood, who is chairman of the Assembly Health Committee, said drug coupons are used as a “marketing tool to drive patients to higher-priced drugs,” and that their use ultimately drives up the cost of health insurance premiums. For more information click here and go under California News. 

COA is seeking your feedback regarding difficulty obtaining Cost Exceed overrides with Optum Rx Insurance. It appears the new year brought a change whereby all override requests can only be obtained through Briova Specialty Pharmacy. For more information click here and go under MOASC News. 

Dr. Cary Presant was invited by the White House to represent MOASC in discussions on Making Health Care Better – Community Oncology, the Moonshot, followed by discussions with the Senate on Innovation and Access in Quality Cancer Care on January 11, 2017. He is author of “Surviving American Medicine.”  For more information click here and go under National News.

The Healthcare Leadership Council (HLC), a coalition of leaders from all sectors of American healthcare, last week, endorsed legislation that would repeal the Independent Payment Advisory Board (IPAB), a panel of political appointees that will have power to initiate arbitrary cuts to the Medicare program and undermine healthcare access and quality for millions of seniors and Americans with disabilities. For more information click here and go under National News.

COA would like for you to please read the article below from the National Community Pharmacists Association (NCPA). They have been fighting this battle on DIR fees for some time as COA had discussed last year. It is quite supportive of the COA position on DIR fees since they also share the same points brought out in the COA white paper.  For more information click here and go under Affiliate News.

 

To view the complete California Oncology Weekly Newsletter click on the date below.

February 7, 2017